Opus Genetics (IRD) executive Jayagopal sold 7,542 shares for $39.2K at $5.19
Insider transactions reported
Ashwath Jayagopal (Chief Scientific & Dev. Ofc. at Opus Genetics Inc., IRD) reported that they sold 7,542 shares for $39.2K at $5.19 on Apr 23, 2026. After these transactions the filing shows 509,233 shares held directly.
- Reporting person
- Jayagopal Ashwath
- Role
- Chief Scientific & Dev. Ofc.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Open-market sale (S) | Common Stock1, 2 | -7,542 | $5.19 | $39.2K | 509,233 direct |
Holdings before and after
- Common Stock: 516,775 to 509,233 direct
Footnotes from the filing
- 1. The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
- 2. The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.18 to $5.21, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Jayagopal report in this IRD Form 4?
Ashwath Jayagopal (Chief Scientific & Dev. Ofc. at Opus Genetics Inc., IRD) reported that they sold 7,542 shares for $39.2K at $5.19 on Apr 23, 2026. After these transactions the filing shows 509,233 shares held directly.
How many IRD shares does Jayagopal hold after this filing?
The filing shows 509,233 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this IRD insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for IRD
Across the 27 sessions after earlier IRD headlines, the stock closed higher 13 times and lower 13 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IRD | SPY |
|---|---|---|---|
| Apr 27, 2026 | Opus Genetics to Participate in Leading Medical Conferences in May 2026 | -2.1% | +0.2% |
| Apr 10, 2026 | Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting | -2.5% | -0.1% |
| Apr 6, 2026 | Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital | +1.3% | +0.5% |
| Mar 30, 2026 | Cantor Fitzgerald initiated coverage on Opus Genetics with a new price target | +0.0% | -0.3% |
| Mar 24, 2026 | Opus Genetics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 | -1.7% | -0.3% |
| Mar 16, 2026 | Oppenheimer initiated coverage on Opus Genetics with a new price target | +3.2% | +1.0% |
Earlier insider filings at IRD
- Apr 27, 2026Chief Financial Officer Gagnon Robert E. sold $40,658 worth of shares (7,842 units at $5.18), decreasing direct ownership by 1% to 592,158 units (SEC Form 4) (withholding obligation)
- Apr 22, 2026SEC Form 4 filed by Rodgers Richard J
- Apr 22, 2026SEC Form 4 filed by Manuso James S J
- Apr 22, 2026SEC Form 4 filed by Benton Susan
- Apr 22, 2026SEC Form 4 filed by Gallagher Cam
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow IRD and get a push notification the moment its next story breaks.